It has high affinity for SSTR-1, SSTR-2, SSTR-3 and most importantly SSTR-5 and presents hyperglycemia as a common adverse effect, but experience in malignant INSs is very limited [125,126,127]. Here, SSTR5 is linked to Hyperglycemia.